Impact of a weekly glucagon-like peptide 1 receptor agonist, albiglutide, on glycemic control and on reducing prandial insulin use in type 2 diabetes inadequately controlled on multiple insulin therapy: a randomized trial
Instead, it bears the status of a research compound that can be legally obtained only by scientists and used for research
BPC-157's rise coincided with the growing popularity of biohacking, longevity, and performance optimization culture
GLP-1 has multiple beneficial effects in cardiovascular diseases such as hypertension, myocardial ischemia, atherosclerosis, and heart failure
However, there is In people without a fatty acid oxidation defect, the benefits of L-carnitine are Fat burning L-carnitine is frequently marketed as a weight loss supplement, but the research is inconclusive